Online citations, reference lists, and bibliographies.
← Back to Search

Histological, Molecular And Functional Subtypes Of Breast Cancers

G. Malhotra, X. Zhao, H. Band, V. Band
Published 2010 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Increased understanding of the molecular heterogeneity that is intrinsic to the various subtypes of breast cancer will likely shape the future of breast cancer diagnosis, prognosis, and treatment. Advances in the field over the last several decades have been remarkable and have clearly translated into better patient care as evidenced by the earlier detection, better prognosis, and new targeted therapies. There have been two recent advances in the breast cancer research field that have lead to paradigm shifts: first, the identification of intrinsic breast tumor subtypes, which has changed the way we think about breast cancer and second, the recent characterization of cancer stem cells (CSCs), which are suspected to be responsible for tumor initiation, recurrence and resistance to therapy, have opened new exciting avenues to think about breast cancer therapeutic strategies. While these advances constitute major paradigm shifts within the research realm, the clinical arena has yet to adopt and apply our understanding of the molecular basis of the disease to early diagnosis, prognosis and therapy of breast cancers. Here, we will review the current clinical approach to classification of breast cancers, newer molecular-based classification schemes, and potential future of biomarkers representing a functional classification of breast cancer.
This paper references
High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival.
K. Friedrichs (1995)
10.1038/nature04372
Generation of a functional mammary gland from a single stem cell
M. Shackleton (2006)
10.1200/JCO.2009.23.2439
Reply to C. Badoual et al
P. Salama (2009)
10.1101/gad.1849509
Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis.
J. Visvader (2009)
10.1016/j.cell.2009.12.007
Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
S. Pece (2010)
10.1038/nature04496
Purification and unique properties of mammary epithelial stem cells
J. Stingl (2006)
10.1007/s10549-010-0746-x
Combinatorial biomarker expression in breast cancer
E. Rakha (2010)
10.1182/BLOOD-2004-02-0448
Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity.
D. Hess (2004)
Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
D. Poller (1994)
10.1038/sj.bjc.6602787
Clinical characteristics of different histologic types of breast cancer
C. Li (2005)
10.1200/JCO.2008.18.1370
Supervised risk predictor of breast cancer based on intrinsic subtypes.
J. Parker (2009)
10.1111/j.1365-2559.2007.02897.x
Predictive markers in breast cancer – the present
S. Payne (2008)
10.1073/pnas.1009030107
Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate
X. Zhao (2010)
10.1073/pnas.0932692100
Repeated observation of breast tumor subtypes in independent gene expression data sets
T. Sørlie (2003)
Ductal carcinoma in situ: a proposal for a new classification.
R. Holland (1994)
10.1007/s10549-009-0619-3
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment
E. Resetkova (2009)
10.1043/1543-2165-133.10.1515
Protocol for the examination of specimens from patients with invasive carcinoma of the breast.
S. Lester (2009)
10.1043/1543-2165-133.10.1515
Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast
J. Misdraji (2009)
10.1073/pnas.191367098
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T. Sørlie (2001)
10.1056/NEJMOA063994
The prognostic role of a gene signature from tumorigenic breast-cancer cells.
R. Liu (2007)
An entire functional mammary gland may comprise the progeny from a single cell.
E. Kordon (1998)
10.1016/j.stem.2007.08.014
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
C. Ginestier (2007)
10.2353/ajpath.2010.090712
In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.
V. Neumeister (2010)
10.1186/gb-2007-8-5-r76
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
J. Herschkowitz (2006)
10.1038/35021093
Molecular portraits of human breast tumours
C. Perou (2000)
10.1158/1078-0432.CCR-08-1479
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
T. Tanei (2009)
10.1002/1097-0142(19890215)63:4<618::AID-CNCR2820630403>3.0.CO;2-J
Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence
M. Lagios (1989)
10.1073/PNAS.96.16.9118
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity.
R. Storms (1999)
10.1073/pnas.0530291100
Prospective identification of tumorigenic breast cancer cells
M. Al-Hajj (2003)
10.1186/bcr2635
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
A. Prat (2010)
10.1200/JOP.0768504
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer.
Lyndsay Harris (2007)
10.1634/theoncologist.2007-0248
Commercialized multigene predictors of clinical outcome for breast cancer.
J. Ross (2008)
10.1038/nm.2000
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers
E. Lim (2009)
Recommendations for the reporting of breast carcinoma. Association of Directors of Anatomic and Surgical Pathology.
(1996)
10.1158/1078-0432.CCR-09-1532
Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
S. Park (2010)
10.6004/JNCCN.2009.0027
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
A. Benson (2009)
[Treatment of breast cancer].
L. Arrighi (1971)
10.1038/nrc2212
Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
J. Stingl (2007)
10.1016/S0140-6736(95)90982-6
Prognostic classification of breast ductal carcinoma-in-situ
D. Poller (1995)
10.1158/0008-5472.CAN-08-2741
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.
E. Charafe-Jauffret (2009)
10.1073/PNAS.0603806103
Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells.
J. Chute (2006)
Recommendations for the reporting of breast carcinoma. Association of Directors of Anatomic and Surgical Pathology.
(1995)
10.1634/stemcells.2005-0217
Identification of a Primitive Brain–Derived Neural Stem Cell Population Based on Aldehyde Dehydrogenase Activity
S. Corti (2006)



This paper is referenced by
10.1159/000491463
Activator Protein-2β Promotes Tumor Growth and Predicts Poor Prognosis in Breast Cancer
Z. Li (2018)
10.1016/j.cellsig.2016.06.011
The protein phosphatase 4 - PEA15 axis regulates the survival of breast cancer cells.
H. Mohammed (2016)
10.30574/wjarr.2020.5.2.0014
Pattern of breast cancer presentation in a tertiary hospital in Lagos, Nigeria
Adeyanju Michael Abiodun (2020)
10.7282/T3319XHP
A Panoptic Approach to Studying MicroRNA Expression in Breast Tumors
Priyanka Bhatt (2014)
Metabolic and immunological interactions between adipose tissue and breast cancer - implications of obesity in tumor progression
Peter Micallef (2019)
Effects of miR-376 family miRNAs on CHRNA5 depleted MCF7 cell line model and co-culture competition studies
Rafed Said Tiryaki (2019)
10.1002/jcp.26116
Aberrant miRNA promoter methylation and EMT‐involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications
M. Zare (2018)
10.26911/THEIJMED.2016.01.01.04
MiR-21 Expression in Grade I, II, and III Breast Cancer
Juwita Juwita (2016)
A Generalized Deep Learning Framework for Whole-Slide Image Segmentation and Analysis
Mahendra Khened (2020)
10.1002/0471141755.ph1436s70
Overview of Genetically Engineered Mouse Models of Breast Cancer Used in Translational Biology and Drug Development
K. Greenow (2015)
10.1016/j.bbrep.2020.100844
SARS-CoV-2 cell receptor gene ACE2 -mediated immunomodulation in breast cancer subtypes
Vikas Kumar Bhari (2020)
Breast Cancer Disparities in African American Women: Does Race or Place Matter?
C. Algarra Lucas (2017)
10.1038/s41389-020-00255-1
AUF1 promotes stemness in human mammary epithelial cells through stabilization of the EMT transcription factors TWIST1 and SNAIL1
Manar M. AlAhmari (2020)
Health outcomes of women with breast cancer
E. Colzani (2014)
Influence of low penetrance genes in susceptibility for breast cancer in the portuguese population of Beira Interior
A. C. Ramalhinho (2014)
Importance of different growth factors in oestrogen receptor-negative breast cancer
Mercedeh Arasta (2015)
Neoadjuvant treatment of HER 2-positive breast cancer – pathological complete response ( pCR ) as a surrogate of long term outcomes in the context of regulatory guidelines and reimbursement recommendations
A. Panasiuk (2018)
Clinical and Histopathological Parameters of the Patients with Breast Cancer from North West Pakistani Population
A. Ali (2017)
10.32532/jori.v9i2.92
Cancer Profile in North Jakarta and Kepulauan Seribu : A 5-year descriptive study
S. Gondhowiardjo (2018)
The Role of Immunological Receptors CD74 and CD44 in Association with the Macrophage Migration Inhibitory Factor (MIF) on Human Breast Cancer Derived Cells
Hussain Al Ssadh (2016)
10.1016/j.lfs.2019.116945
MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
Mohammad-Nazir Menbari (2019)
10.1186/s12918-016-0306-z
Classification of breast cancer patients using somatic mutation profiles and machine learning approaches
Suleyman Vural (2016)
10.2174/1871520620666200502002609
Preparation and Preliminary Evaluation of 68Ga-Acridine: An Attempt to Study the Potential of Radiolabeled DNA Intercalator as a PET Radiotracer for Tumor Imaging.
S. Ghosh (2020)
Hereditary predisposition to breast cancer : evaluating the role of rare copy number variant, protein-truncating and missense candidate alleles
Anna Tervasmäki (2018)
10.1186/1753-6561-7-S2-P69
Genetic profile analysis of tumor stem cells in locally advanced breast cancer
W. Silveira (2013)
10.35787/JIMDC.V8I2.354
Evolution of Breast Cancer Classification Towards Personalized Medicine
N. Hadi (2019)
The effect of imidazo [1,2-a] pyridine amines on MCF-7 and MDA-MB-231 breast cancer cells
T. Kurebwa (2015)
Development of antibodies against the Notch pathway ligand JAG1 using phage display technology
Gonçalo Marques (2019)
Biological evidence of the protective role of regucalcin in breast cancer
Ricardo J. Marques (2016)
10.1007/s12672-020-00393-3
Prevalence of Histological Characteristics of Breast Cancer in Rwanda in Relation to Age and Tumor Stages
J. P. Uyisenga (2020)
A fatal gastric perforation secondary to ulcerated metastasis in undiagnosed breast cancer: pathological aspects and review of literature.
R. Barranco (2017)
Quantifying Subtle Regions of Order and Disorder in Tumor Architecture by Calculating the Nearest-Neighbor Angular Profile
David H. Nguyen (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar